Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes

Go back to Tandem Diabetes (TNDM) Care Announces FDA Clearance of Control-IQ+ Automated Insulin Delivery Technology for People with Type 2 Diabetes
TANDEM DIABETES (NASDAQ: TNDM) Delayed: 19.90 -0.53 (2.59%)
Previous Close $20.43    52 Week High $12.48 
Open $20.04    52 Week Low $1.60 
Day High $20.36    P/E N/A 
Day Low $19.49    EPS $-6.33 
Volume 1,363,548